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surface. Choline binding proteins, including pneumo-
coccal surface protein A (PspA) (Yother and White, 1994)
and choline binding protein A (CbpA) (Rosenow et al.,
1997), are tethered to pneumococcal surface choline via
a highly conserved choline binding domain.
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CbpA was originally reported in the S. pneumoniaeSt. Jude Children’s Research Hospital
serotype 2 derivative R6x (Rosenow et al., 1997), and itMemphis, Tennessee 38105
has been identified in virtually all pneumococcal sero-†Department of Anatomy
types tested thus far (E. T., unpublished data). In sero-University of California, San Francisco
type 2, mature CbpA consists of 663 amino acids with
San Francisco, California 94143
a predicted mass of 75 kDa (Rosenow et al., 1997). The‡Department of Pathology C-terminal region represents a choline binding domain
Case Western Reserve University consisting of 10 tandem repeats of 20 amino acids (Fig-
Cleveland, Ohio 44106 ure 1A). The N-terminal region is predicted to contain
§Yakult Central Institute for Microbiological six a-helical structures, forming two direct repeats of
Research 107 amino acids, designated R1 and R2 (Figure 1A).
Tokyo Sequence alignment revealed 89% amino acid identity
Japan between R1 and R2 (Figure 1B). CbpA has been sug-
gested to function as a pneumococcal adhesin (Ro-
senow et al., 1997). Genetic disruption of cbpA led to
decreased adherence to human cells. In addition, theSummary
CbpA-deficient mutant also exhibited dramatic loss of
nasopharyngeal colonization in rats (Rosenow et al.,The polymeric immunoglobulin receptor (pIgR) plays
1997). The host receptor for the pneumococcal CbpAa crucial role in mucosal immunity against microbial
is unknown.infection by transporting polymeric immunoglobulins
The polymeric immunoglobulin receptor (pIgR), an in-(pIg) across the mucosal epithelium. We report here
tegral membrane protein, is required for transcytosis ofthat the human pIgR (hpIgR) can bind to a major pneu-
polymeric immunoglobulins (pIg) including IgA and IgMmococcal adhesin, CbpA. Expression of hpIgR in hu-
across mucosal epithelial cells (Mostov and Kaetzel,man nasopharyngeal cells and MDCK cells greatly en-
1999). pIgR has an N-terminal ligand binding domain, ahanced pneumococcal adherence and invasion. The
single membrane spanning region and a short cyto-hpIgR-mediated bacterial adherence and invasion
plasmic C-terminal tail. While mature hpIgR has a pre-
were abolished by either insertional knockout of cbpA dicted mass of 81.5 kDa, the migration of the protein
or antibodies against either hpIgR or CbpA. In con- varies from 100 kDa to 120 kDa (Mostov and Blobel,
trast, rabbit pIgR (rpIgR) did not bind to CbpA and its 1982) due to differential glycosylation of the receptor
expression in MDCK cells did not enhance pneumo- (Tomana et al., 1978; Mizoguchi et al., 1982). After syn-
coccal adherence and invasion. These results suggest thesis by plasma cells, commonly located in the lamina
that pneumococci are a novel example of a pathogen propria of the mucosal membrane, polymeric IgA and
co-opting the pIg transcytosis machinery to promote IgM bind covalently to pIgR expressed on the basolat-
translocation across a mucosal barrier. eral surface of the epithelial membrane. The pIg-pIgR
complex is then transported via a series of endosomal
Introduction compartments across the epithelium to the mucosal
surface, where it is released into mucosal secretions.
The extracellular, ligand binding portion of pIgR (z550Streptococcus pneumoniae is a major pathogen that
causes invasive infections such as sepsis, meningitis, amino acids of 764 amino acids for human pIgR), known
as the secretory component (SC), is proteolyticallyand pneumonia (Alonso de Velasco et al., 1995). The
pneumococcus colonizes the nasopharyngeal epithe- cleaved off from the apical surface of the epithelial cells
and released together with pIg. Association of SC withlium and penetrates the epithelium of the nasopharynx
or lung to reach the vascular compartment. The molecu- IgA is believed to protect it from proteolytic degradation
by bacterial proteases (Kobayashi, 1971; Kilian et al.,lar mechanisms for pneumococcal adherence and inva-
sion are poorly understood. Phosphorylcholine on the 1988). The secreted pIg-SC complex is known as secre-
tory immunoglobulin. Secretory IgA (S-IgA) in the respi-pneumococcal cell wall has been implicated as an adhe-
sive ligand for the receptor of platelet-activating factor ratory secretions plays an essential role in mucosal im-
(PAF) present on the surface of lung epithelial and vascu- munity by opsonizing bacteria (Fubara and Freter, 1973;
lar endothelial cells (Cundell et al., 1995). Binding to the McNabb and Tomasi, 1981; Daniele, 1990). A pneumo-
PAF receptor enhances pneumococcal adherence and coccal surface protein designated SpsA was reported
invasion of host cells. Phosphorylcholine on the bacte- to specifically bind to SC and S-IgA but not serum (mo-
rial cell surface also serves to anchor a family of bacterial nomeric) IgA (Hammerschmidt et al., 1997). Sequence
proteins—the choline binding proteins—to the bacterial comparison reveals high homology between SpsA and
CbpA. The pathogenic significance of the SC/S-IgA
binding activities has not been determined.k To whom correspondence should be addressed (e-mail: elaine.
tuomanen@stjude.org). We sought to determine the identity of the human cell
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Figure 1. Identification of hpIgR as a CbpA-
Binding Protein
(A) Schematic illustration of CbpA structure
and truncate construction. CbpA in serotype
2 contains a C-terminal choline binding do-
main (CBD) and two N-terminal repetitive re-
gions R1 and R2. Truncated polypeptides
(CbpA1–4) are depicted with the beginning
and ending of the amino acid residues in the
constructs.
(B) Peptide sequence alignment of the N-ter-
minal CbpA repeats R1 and R2. Identical and
similar residues are marked as vertical lines
and dots, respectively.
(C) Purification of hpIgR by a CbpA-affinity
column as detected by binding of streptavidin
(left) or an anti-hpIgR serum (middle). The
N-terminal peptide sequences of hpIgR and
the 120 kDa and 100 kDa proteins are shown
on the right. The numbers (1–7) and the letter
(b) at the top indicate the column fractions
following addition of 100 mM glycine-HCl (pH
2.5) and the unfractionated biotin-labeled De-
troit cell extract, respectively. Molecular sizes
are in kDa.
receptor(s) for CbpA responsible for mediating nasopha- with streptavidin. This reactivity suggested surface lo-
calization of these proteins. No additional protein bandsryngeal adherence of S. pneumoniae. Host receptors
for several bacterial proteins including Yersinia pseudo- labeled with streptavidin were detected in the CbpA1-
affinity purified material.tuberculosis invasin (Isberg and Leong, 1990), Listeria
monocytogenes internalin (Mengaud et al., 1996), and To identify the CbpA binding proteins, the two protein
bands were excised from the gels and subjected toEscherichia coli Ibe10R (Prasadarao et al., 1999), have
been successfully isolated by using a solid matrix bear- N-terminal amino acid sequencing. Sequence analysis
revealed almost identical sequences (Figure 1C, right)ing purified bacterial protein to capture host cell ligands.
In this study, using a similar affinity chromatography that matched the N-terminal amino acid sequence of
hpIgR (SWISS-PROT accession P01833). To further ver-strategy, we identified a surface protein from human
nasopharyngeal cells that binds to the N-terminal repeat ify the peptide sequencing results, an antibody against
hpIgR was used to react with an immunoblot of theregions of CbpA. Peptide sequence analysis revealed
that the CbpA binding protein was human pIgR. Expres- CbpA-column eluates. While the serum control did not
show detectable reactivity (data not shown), the anti-sion of hpIgR in human nasopharyngeal cells and Madin-
Darby canine kidney (MDCK) cells substantially facili- pIgR antibody bound the two streptavidin-labeled CbpA
binding proteins (Figure 1C, middle). This suggests thattated adherence and invasion of pneumococci.
the two CbpA binding proteins isolated by CbpA affinity
chromatography represent two forms of hpIgR as de-Results
scribed previously (Mostov and Blobel, 1982) and that
hpIgR is a cellular receptor for pneumococcal CbpA inCbpA Binds to hpIgR
human nasopharyngeal cells.Our goal was to identify a potential host receptor(s) for
pneumococcal CbpA in human nasopharyngeal epithe-
lial cells. A series of CbpA polypeptides were expressed Interaction of CbpA with hpIgR Enhances
Adherence and Invasion in Detroit Cellsin E. coli (Figure 1A). To improve solubility, the C-terminal
choline binding domain of CbpA was deleted, leaving To determine if CbpA served as a functional bacterial
ligand for hpIgR, adherence and invasion were quanti-the N-terminal majority of the protein bearing the cell
binding activity (Rosenow et al., 1997). Recombinant tated using S. pneumoniae R6x and an isogenic CbpA
mutant. Compared with the R6x parent strain, the CbpACbpA1 coupled covalently to agarose matrices was
used to purify CbpA binding protein(s) from human naso- mutant substantially lost its ability to adhere to Detroit
cells (Figure 2A). The R6x bacteria were capable of entrypharyngeal cells (Detroit-562 cell line). Detroit cells were
surface-labeled with biotin and detergent-soluble pro- into the Detroit cells (Figures 2B and 2C). In contrast,
the CbpA mutant retained less than 10% of the invasionteins were run through a CbpA1 affinity column. The
bound proteins were eluted at pH 2.5 and subjected capability shown by its parent strain (Figure 2C), con-
firming that CbpA is a significant ligand for pneumococ-to SDS-PAGE electrophoresis, and biotinylated human
proteins were detected through the binding of streptavi- cal adherence and invasion. Treating R6x with an anti-
body against CbpA1 (Figure 1A) almost completelydin-peroxidase conjugates. As shown in Figure 1C (left),
this procedure revealed two bound proteins with molec- blocked bacterial adherence (not shown) and invasion
(Figure 2C).ular sizes of 100 and 120 kDa that both strongly reacted
Human pIgR and Pneumococcal Invasion
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Figure 2. Correlation of R6x Adherence and
Invasion with Expression of hpIgR in Detroit
Cells
(A) Adherence of R6x (left) or the isogenic
CbpA2 mutant (right) to Detroit cells. Bacteria
were incubated with Detroit cells for 1 hr fol-
lowed by extensive washing. Diff-Quik stain-
ing revealed the adherent bacteria (small blue
dots) and host cells with large nuclei (purple
bodies).
(B) R6x invasion in Detroit cells as visualized
by transmission electron microscopy. Bacte-
rial cells (dark bodies) are shown during initial
entry at the surface of the host cell (left) or
during internalization into the cell (right). Bar
is 0.45 mm (left) or 1.2 mm (right).
(C) Effects of loss of CbpA or hpIgR function
on R6x invasion in Detroit cells. R6x and the
isogenic CbpA mutant R6x (CbpA2 were in-
cubated with Detroit cells in 24-well plates.
After killing extracellular bacteria with antibi-
otics, intracellular bacteria were released by
detergent lysis of the cells and quantitated
by plating the cell lysates on TSA blood
plates. For blocking experiments with anti-
CbpA serum or anti-hpIgR serum, R6x bacte-
ria or the cell monolayers were treated with
a 1:50 dilution of antiserum or normal rabbit
serum (NRS) for 30 min before R6x infection.
All assays were performed in 4–6 parallel
wells at least three independent times. Re-
sults of representative experiments are pre-
sented as mean 1 standard deviation.
(D) Comparison of R6x invasion in different
human cell lines. In the inset, immunoblots of
human cell lysates were detected by using a
rabbit anti-hpIgR serum. The hpIgR-express-
ing MDCK cells (hSC-1) and the MDCK cells
transfected with the pCB6 vector only (Neo-1)
were used as controls for immunoblot analy-
sis. R6x and the CbpA mutant were used to
perform invasion assays with four human cell
lines as in (C).
(E) Enhancement of R6x invasion by treating
Detroit cells with cytokines. Prior to bacterial
infection, Detroit cells were treated with cyto-
kines for 12 hr at 378C. Blocking experiments
with anti-hpIgR (anti-hSC) were performed as
in (C).
To determine the role of hpIgR in CbpA-dependent These results strongly suggested a specific role for
CbpA-hpIgR interaction in pneumococcal adherenceadherence and invasion, Detroit cells were treated with
the antibody against hpIgR prior to bacterial infection. and invasion in human nasopharyngeal cells.
Cellular pIgR expression is upregulated by proinflam-The antibody treatment reduced R6x adherence and
entry to levels similar to those of the CbpA mutant (Fig- matory cytokines in a variety of cell types (Mostov and
Kaetzel, 1999). As shown in Figure 2E, Detroit cellsure 2C), suggesting that hpIgR is important for pneumo-
coccal adherence and entry into human nasopharyngeal treated with INF-g took up z4-fold more R6x bacteria
than the untreated cells; TNF-a, IL1-a, and IL-4 had noepithelial cells.
Several human cell lines derived from lung (Talbot et significant effect on R6x invasion. In contrast, INF-g
treatment did not enhance invasion level of the CbpAal., 1996; Rosenow et al., 1997), larynx (El Ahmer et al.,
1999), and blood-brain barrier (Ring et al., 1998), have mutant. Finally, the cytokine-induced increase in R6x
invasion was reduced to the background level by thebeen used to study pneumococcal adherence and/or
invasion. In contrast to Detroit cells, A549 (alveolar lung antibody against hpIgR (Figure 2E), indicating that the
cytokine-enhanced pneumococcal invasion was due tocell line), HEp-2 (laryngeal cell line), and KC (brain mi-
croendothelial cell line) did not show detectable levels specific upregulation of hpIgR expression.
of hpIgR expression (Figure 2D, inset). Accordingly, R6x
showed substantially lower adherence (data not shown) Human but Not Rabbit pIgR Promotes Bacterial
and invasion in HEp-2, A549, and KC cells (Figure 2D) Entry in MDCK Cells
when compared to Detroit cells. The CbpA mutant ex- To more definitively characterize the interaction of CbpA
hibited similar very low degrees of adherence (not with hpIgR, a model system for pIgR-dependent trans-
cytosis was used (Tamer et al., 1995). Compared withshown) and invasion (Figure 2D) in all four cell lines.
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There is a high level of sequence diversity among
the pIgR variants of mammalian species (Mostov and
Kaetzel, 1999). For example, hpIgR and the rabbit pIgR
(rpIgR) share only a 50% amino acid homology. Since
the pneumococcus resides in the human but not rabbit
nasopharynx, we examined whether rpIgR could also
promote pneumococcal adherence and invasion. MDCK
cells transfected with rpIgR (clone A4) were used to
perform adherence and invasion assays with R6x. Al-
though the A4 clone has been shown to support IgA
transcytosis (Singer and Mostov, 1998), it did not signifi-
cantly enhance R6x adherence (Figure 3A) and invasion
(Figure 3B) as compared with the vector control (Neo-1).
Similar results were also obtained with a second inde-
pendent rpIgR transfectant (clone pWE) (Breitfeld et al.,
1989) (data not shown). Treatment with a sheep antise-
rum against rpIgR did not block R6x invasion of the
hpIgR-transfected MDCK cells or Detroit cells. The re-
sults suggest that rpIgR does not serve as a receptor
for pneumococcal CbpA.
CbpA-Coated Beads Are Able to Enter the Cells
Expressing hpIgR
To assess whether CbpA was sufficient to mediate bac-
terial adherence and invasion, inert latex beads were
coated with CbpA1. CbpA1-coated beads were allowed
to interact with cells in a fashion similar to that of intact
bacteria. While latex beads coated with bovine serum
albumin (BSA) were only occasionally associated with
the apical surface of cells (data not shown), the CbpA1-
coated particles were attached (Figure 4A) and internal-
ized into Detroit cells (Figure 4B). The attachment of
CbpA1-coated beads to Detroit cells depended on pro-
tein concentration of CbpA1 but not BSA as assessed
by fluorescence microscopy (Figure 4C). The CbpA1-
coated beads were also internalized into the hpIgR-Figure 3. Enhancement of R6x Adherence and Invasion by Expres-
expressing MDCK cells (clone hSC-1) but not in vectorsion of hpIgR in MDCK Cells
control MDCK cells (Neo-1) (data not shown).(A) Adherence of R6x (left) or the CbpA2 mutant (right) to MDCK cells
transfected with pCB6 vector alone (Neo-1), pCB6-hpIgR (hSC-1) or
pCB6-rpIgR (A4). Adherence was determined as in Figure 2A. N-Terminal Repeated Regions of CbpA Interact
(B) Invasion of MDCK cells by R6x and the CbpA mutant. Invasion with hpIgR
was determined as in Figure 2C. To determine which part of the CbpA protein interacts
(C) Blocking of R6x invasion of hSC-1 cells by anti-CbpA or anti-
with hpIgR, a series of CbpA polypeptides were con-hpIgR sera. Antibody blocking experiments were carried out as in
structed (Figure 1A). Equimolar amounts of the CbpAFigure 2C.
truncates (4.2 nmol) were then immobilized on latex
beads to precipitate hpIgR from Detroit cell extract. Im-
munoblot analysis showed that the CbpA1-coated
the MDCK cells transfected with the vector alone beads precipitated hpIgR in the cell extract prepared
(Neo-1), R6x showed greatly enhanced adherence to the from the hpIgR transfectant hSC-1, but not in the extract
hpIgR transfectant (clone hSC-1) (Figure 3A). In contrast, of the vector only control Neo-1 (Figure 5A). Similarly,
the CbpA mutant had similar degrees of adherence to the CbpA polypeptides containing either R1 (CbpA2) or
Neo-1 and hSC-1 (Figure 3A). hSC-1 took up 10-fold R2 (CbpA3) or both repeats (CbpA1) were able to bind
more bacteria in a standard invasion assay when com- to hpIgR in Detroit cell extract (Figure 5A). In contrast,
pared with Neo-1 (Figure 3B). To exclude the possibility the very N-terminal region (CbpA4), lacking both R1 and
of clonal variation, an independent hpIgR transfectant R2 repeats, did not show detectable binding to hpIgR
(clone 4) (Tamer et al., 1995) was used to repeat the (Figure 5A), strongly suggesting that R1 and R2 repeats
invasion assay. The results obtained with clone 4 were are responsible for hpIgR binding activity. As an addi-
similar to those of hSC-1 (data not shown). In contrast, tional control, the beads coated with recombinant form
the CbpA mutant showed similar levels of invasion in of VncS, another pneumococcal membrane protein (No-
both cell types (Figure 3B). The specificity of the en- vak et al., 1999), did not show detectable binding to
hanced pneumococcal invasion in hpIgR transfectants hpIgR (Figure 5A). Since the recombinant form of the
was further confirmed by using antibodies against hpIgR C-terminal choline binding domain was insoluble, we
or CbpA (Figure 3C). Taken together, these data demon- were unable to assess its role in hpIgR binding activity.
strated that specific interaction between pneumococcal To determine whether CbpA could bind to the rabbit
CbpA and hpIgR promotes bacterial adherence and in- pIgR, the CbpA1-coated beads were incubated with cell
extracts prepared with the rpIgR transfectant (clone A4)vasion.
Human pIgR and Pneumococcal Invasion
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Figure 5. Binding of the N-Terminal CbpA Repeats to hpIgR
(A) Precipitation of hpIgR by CbpA-coated beads. Latex beads cova-
lently coated with 4 nmol/109 beads of CbpA truncates (CbpA1–4)
were incubated with the cell lysates of Detroit cells (DL) or MDCK
cells (hSC-1 and Neo-1). Following removal of unbound proteins by
extensive washing, proteins bound to the beads were eluted and
separated in an SDS-PAGE gel and immunoblotting was performed
using a rabbit anti-hpIgR serum. Beads coated with the same
amount of BSA or recombinant VncS were processed in a similar
manner. Molecular sizes are in kDa.
(B) Blocking R6x invasion by CbpA polypeptides. Detroit cells were
incubated in the absence (None) or presence of 0.2 mM CbpA poly-
peptides for 30 min before R6x infection. The recombinant VncS
(0.2 mM) was used as a negative control. Intracellular bacteria were
measured by the invasion assay as in Figure 2C.
Figure 4. Uptake of the CbpA-Coated Beads by Detroit Cells
(A) CbpA1-coated latex beads were incubated with Detroit cells
cultured on coverslips to examine attachment of the beads to the To test if the various regions of CbpA protein were
cell surface by scanning electron microscopy. The attached beads able to block functional interaction of CbpA with hpIgR,
are surrounded by the cell surface adhesion structures. Bar is the recombinant fragments of CbpA were incubated with
0.8 mm. Detroit cells at a final concentration of 0.2 mM before
(B) Detroit cells internalized CbpA1-coated beads. Internalized the bacteria were added. Treating Detroit cell mono-
beads (shown as six intracellular spheres) were detected by trans-
layers with truncated proteins CbpA1–3 blocked R6xmission electron microscopy of ultrathin sections. The white areas
invasion to the background level. In contrast, CbpA4within the beads arise by chemical damage of processing reagents
and the VncS control had no effects on invasion (Figureas shown previously (Lecuit et al., 1997). Bar is 1.6 mm.
5B). Consistent with these results, rabbit antisera(C) CbpA1- or BSA-coated beads were incubated with Detroit cells
grown on chamber slides for 1 hr. Unbound beads were removed against the CbpA1–3 but not CbpA4 blocked R6x inva-
by extensive washing. The beads attached to the cells were quanti- sion (data not shown).
tated by using fluorescence microscopy.
The SC Region of hpIgR Binds to CbpA
SC represents a major component of the pIgR. To testand vector control (Neo-1). While immunoblot analysis
using a sheep anti-rpIgR serum detected the rpIgR band possible binding of CbpA to the SC region of the hpIgR
molecule, purified free human SC was incubated within A4 that was not detected in Neo-1, no CbpA1 binding
protein band was detected in either A4 or Neo-1 (not CbpA1-coated beads. Immunoblot analysis revealed
specific binding of CbpA1 to human SC but not serumshown).
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albumin (Figure 6A). These results were further verified
by effective blocking of R6x invasion with human SC in
Detroit cells (Figure 6B).
Since N-glycosylation sites have been identified in
hpIgR (Tomana et al., 1978; Purkayastha et al., 1979;
Mizoguchi et al., 1982), it was possible that CbpA binds
to hpIgR via oligosaccharides. To examine this possibil-
ity, human SC was pretreated with 20 mM of sodium
periodate before being tested for the ability to block the
CbpA-hpIgR interaction. The periodate treatment did
not significantly alter the binding activity of human SC
to CbpA1 (Figure 6A) or its inhibitory effects on R6x
invasion in Detroit cells (Figure 6B), suggesting that the
carbohydrates decorating hpIgR may not be required
for the interaction between hpIgR and CbpA.
The hpIgR-Mediated Invasion Is Independent
of the PAF Receptor
A previous study has shown that phosphorylcholine ex-
pressed at the pneumococcal surface promotes bacte-
rial adherence and invasion through binding to the PAF
receptor in human lung cells and vascular endothelial
cells (Cundell et al., 1995). Detroit cells treated with a
potent PAF receptor antagonist L123 yielded compara-
ble results as those treated with an inactive isomer L124
in terms of R6x invasion (Figure 6C). Consistently, an
antibody against the human PAF receptor had no inhibi-
tory effect on R6x invasion as compared with the serum
control, which was in sharp contrast to effective block-
ing by the antibody against hpIgR (Figure 6C). We
concluded that the phosphorylcholine-PAF receptor in-
teraction is not required for the hpIgR-mediated pneu-
mococcal invasion at the level of the nasopharynx.
Interaction of CbpA with hpIgR Mediates
Transmigration of the Pneumococcus
To test the availability of hpIgR for bacterial attachment
on the apical surface of fully polarized cells, pneumo-
coccal invasion was determined with MDCK cell mono-
layers grown on Transwell membranes. Similar to the
results obtained with the cells cultured on plastic sur-
faces (Figure 3B), the hpIgR transfectant hSC-1 cultured
on Transwell membranes took up 15-fold more R6x bac-
teria than the vector control Neo-1 (Figure 7A). R6x inva-
sion was reduced to the background level by either
Figure 6. Binding of SC to CbpA
treating the hpIgR transfectant hSC-1 with the antiserum
(A) CbpA1-coated beads were incubated with human free SC (hSC),against hpIgR or genetic disruption of CbpA expression
SC treated with sodium periodate (hSC-sp), human serum albumin
in R6x. These results indicated that sufficient quantities (HSA), or HSA treated with sodium periodate (HSA-sp). BSA-coated
of hpIgR are expressed on the apical surface of polarized beads were incubated with SC as a control (right lane, left panel).
hpIgR-expressing cells to promote pneumococcal at- Immunoblots of human SC (left lane, left panel) and the precipitated
tachment and invasion. materials were reacted with antiserum against human SC (left and
right panels) or HSA (middle panel).To determine if this CbpA-hpIgR interaction could fa-
(B) R6x bacteria were preincubated with 10 mg/ml human free SCcilitate pneumococcal transmigration, the mixture of
(hSC), SC treated with sodium periodate (hSC-sp), HSA, or HSAR6x and the CbpA mutant (1:1) were incubated with the
treated with sodium periodate (HSA-sp) for 30 min at 378C beforeDetroit cells in the upper chamber. Extracellular bacteria
addition to Detroit cells. Intracellular bacteria were measured by thewere then eliminated with antibiotics, and pneumococ-
invasion assay as in Figure 2C.
cal transmigration was determined by measuring the (C) Before R6x infection, Detroit cells were incubated at 378C for
number of bacteria in the lower chamber. As shown 30 min in the absence (None) or presence of 2 mM PAF receptor
by Ring et al. (1998), pneumococcal infection did not antagonist (L123), 2 mM inactive isomer of the antagonist (L124),
significantly compromise the integrity of the Detroit control rabbit serum (NRS), rabbit antiserum against hpIgR (a-hSC),
or rabbit antiserum against the human PAF receptor (a-PAFr). Serummonolayers. These experiments revealed a 9:1 ratio of
samples were used at a final dilution of 1:50. Bacterial invasion wastransmigrated bacteria between R6x and the CbpA mu-
quantitated as above.tant, respectively, three hours after antibiotic killing (Fig-
ure 7B). Similarly, the antiserum against hpIgR signifi-
cantly blocked the R6x transmigration across the Detroit
Human pIgR and Pneumococcal Invasion
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infection. Analysis of nasal lavages showed a significant
decrease of nasopharyngeal colonization in pIgR KO
mice as compared with the wild-type controls at both
time points (Figure 7C). Our attempt to determine the
levels of bacterial invasion in pIgR KO mice failed, be-
cause the parental C57Bl/6J mice exhibited very high
resistance to pneumococcal bacteremia. An alternative
approach was developed using 129/SvJ mice lacking a
protein tyrosine kinase of the SRC family, p62yes (Stein
et al., 1994).
p62yes is required in polymeric IgA transcytosis in vivo
(Luton et al., 1999) and thus, the KO mice are functionally
pIgR null. p62yes KO mice were infected intranasally and
bacterial invasion was assessed by collecting blood
samples at 12, 28, and 48 hr post infection. As shown
in Figure 7D, while no pneumococci were detected in
blood at the 12 hr time point, the bacteria were present
in almost all mice in both groups 28 hr after intranasal
inoculation. However, the levels of bacteremia in p62yes
KO mice were significantly lower than those in controlFigure 7. Transmigration and Colonization of the Pneumococcus
mice. Both mouse strains exhibited similar high levels
(A) Availability of hpIgR on the apical surface of the fully polarized
of bacteremia (z10 8 bacteria/ml blood) at the 48 hr timeepithelial cells. MDCK cells transfected with pCB6 vector only
point. We conclude that p62yes KO mice had a delayed(Neo-1) or with the hpIgR cDNA (hSC-1) were allowed to form fully
onset of pneumococcal bacteremia.polarized monolayers on 12 mm Transwell membranes (0.2 mm pore
size) before infection with R6x or the CbpA mutant R6x (CbpA2).
To test the blocking effects of the antiserum against hpIgR on R6x Discussion
invasion, a 1:50 dilution (250 ml) of the rabbit antiserum (anti-hSC)
or control serum (NRS) was incubated with the cell monolayer at
The human nasopharynx is the primary colonization site378C for 30 min before addition of 250 ml R6x suspension (107 bacte-
for S. pneumoniae (Alonso de Velasco et al., 1995). Weria). The invasion experiments were carried out as in Figure 2C.
have shown that hpIgR expressed by human nasopha-(B) Transmigration of R6x across human nasopharyngeal mono-
ryngeal epithelial cells serves as a cellular receptor forlayers. Detroit cells grown on Transwell membranes were infected
with a 1:1 mixture of R6x and the CbpA mutant in the upper chamber. the pneumococcal adhesin CbpA. Molecular affinity be-
Bacteria in the lower chambers were quantitated by plating fractions tween hpIgR and CbpA was demonstrated by specific
of the medium on TSA blood plates with (selecting the CbpA mutant) binding of hpIgR to a CbpA affinity matrix and CbpA-
or without erythromycin (total bacteria). The specific role of hpIgR coated latex beads. The biological result of the specific
in R6x transmigration was assessed by treating the monolayers with interaction of pneumococcal CbpA with hpIgR en-
a 1:50 dilution of the rabbit antiserum against hpIgR (anti-hSC) or
hanced bacterial adherence, invasion, and transmigra-the control serum (NRS) for 1 hr before R6x addition.
tion of the bacteria from the apical to the basolateral(C) Decreased nasal colonization of S. pneumoniae in pIgRKO mice.
face of the mammalian cells.Five pIgR KO and wild-type mice were given 105 CFU of serotype 4
Two N-terminal repetitive regions (R1 and R2) of CbpApneumococcus. The nasal bacteria loads in individual animals were
determined by nasal washing at 12 and 52 hr post inoculation. The appear to independently bind to hpIgR. An affinity col-
results represent one of two experiments performed at different umn constructed with the CbpA1 polypeptide harboring
times. both the R1 and R2 repeats captured hpIgR from a
(D) Delayed onset of pneumococcal bacteremia in p62yes KO mice. Detroit cell extract. Moreover, beads coated with the
Five p62yes KO and control mice were infected intranasally with 105 CbpA truncates containing only R1 and/or R2 specifi-
CFU of serotype 4 pneumococcus. Presented are the levels of bac-
cally precipitated hpIgR in cell extracts of the hpIgR-teremia in individual p62yes KO (open circles) and control mice (filled
expressing cells. In contrast, the CbpA truncate lackingtriangles) at 12 and 28 hr post inoculation. The results represent
both R1 and R2 regions did not show detectable bindingone of two experiments performed at different times. Statistical
to hpIgR. Although the specific residues of the R1 andanalysis as determined by the Mann-Whitney rank sum test supports
significantly different onset levels of bacteremia at 28 hr post inocu- R2 repeats involved in the hpIgR binding remain to be
lation between p62yes KO and control mice (P 5 0.008). determined, high proportions of the charged amino acid
residues lysine and glutamic acid in both R1 and R2
may contribute to the receptor binding. The R1 and R2
monolayers. These data showed that the molecular in- repeats are composed of 54.2% and 56.1% charged
teraction between the pneumococcal ligand CbpA and amino acids, respectively.
its cellular receptor, hpIgR, enables the pneumococci Binding of human free SC to CbpA is consistent with
to transmigrate across human nasopharyngeal epithelial a previous finding that pneumococcal SpsA, a variant
cells. of CbpA, binds to human SC and S-IgA but not serum
(monomeric) IgA which lacks SC (Hammerschmidt et
al., 1997). Lack of binding to the rabbit pIgR by CbpAPneumococcal Colonization and Invasion in Mice
To test whether the CbpA-pIgR interaction participated suggests that the CbpA binding site(s) may be located
in variable regions of hpIgR (Mostov and Kaetzel, 1999).in pneumococcal colonization and invasion, pIgR knock-
out (KO) mice (Shimada et al., 1999) were infected with The CbpA-dependent interaction with the human but
not rabbit pIgR is reminiscent of a previous finding thatserotype 4 pneumococci via intranasal inoculation. Col-
onization and invasion were assessed by collecting na- the surface protein internalin of L. monocytogenes binds
to human E-cadherin but not the highly homologoussal lavages and blood samples at 12 and 52 hr post
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mouse E-cadherin (Lecuit et al., 1999). A single amino Binding to dimeric IgA triggers endocytosis of the com-
acid difference appears to determine the binding speci- plex. Transport of the vesicles containing the pIgR–IgA
ficity in this case. Since periodate treatment had no complex to the apical surface requires microtubules and
effect on the CbpA-SC interaction, the binding specific- actin filaments because both nocodazole (a microtubule
ity of hpIgR for CbpA may be determined by amino acid depolymerizing agent) and cytochalasin D (an actin dis-
differences rather than differential glycosylation. rupting agent) block the transcytosis of dimeric IgA (Ma-
We found that the levels of hpIgR expression in human ples et al., 1997). Free pIgR molecules at the apical
respiratory epithelial cells correlated with the degree of surface exist but are believed to be limited, because
pneumococcal adherence and invasion. Human naso- pIgR targeted to the apical surface has been shown to
pharyngeal epithelial cells (Detroit) were found to ex- be rapidly cleaved off or endocytosed if not cleaved
press hpIgR and take up 10- to 50-fold more R6x bacte- (Breitfeld et al., 1989). Our data support the model that
ria than the cells lacking hpIgR expression such as pneumococci interact with uncleaved hpIgR, in that ex-
epithelial cells derived from the human larynx, lung, and pression of hpIgR in fully polarized MDCK cells on
brain endothelium. The differential expression of hpIgR Transwell filters was accompanied by z15-fold increase
detected in Detroit (nasopharyngeal) and A549 (alveolar) in pneumococcal invasion from apex to base. This im-
cells is consistent with the decreasing gradient of pIgR plies that the pneumococcal CbpA–hpIgR interaction
expression from the upper to lower respiratory tract can drive the transcytotic pathway in reverse from apex
(Mostov and Kaetzel, 1999). pIgR is expressed at high to base.
levels by epithelial cells in the upper respiratory tract
such as the nasopharyngeal mucosa. In contrast, there Experimental Procedures
are only trace amounts of pIgR expression in the lower
Streptococcal Strainsrespiratory tract. Thus, the pneumococcal CbpA-hpIgR
S. pneumoniae R6x (Tiraby and Fox, 1973) is a derivative of theinteraction may contribute to colonization by S. pneu-
unencapsulated Rockefeller strain R36A originally derived frommoniae in the human nasopharynx. This concept is sup-
strain D39 (Avery et al., 1944). The cbpA-deficient mutant was gener-ported by the previous finding that the CbpA-deficient
ated from R6x by insertion of an erythromycin-resistance cassettepneumococci colonize the infant rat nasopharynx at a
as described previously (Rosenow et al., 1997). Pneumococci were100-fold less efficiency than wild-type strain (Rosenow routinely grown as described previously (Zhang et al., 1999).
et al., 1997). The significantly reduced pneumococcal
colonization and delayed onset of sepsis in pIgR and Epithelial Cell Lines
p62yes knockout mice, respectively, also provide direct Wild-type MDCK strain II cells were obtained from the American
evidence to support this idea. The lack of detectable Type Culture Collection (ATCC) (Manassas, VA). MDCK cells stably
hpIgR expression in lung alveoli and vascular endothe- transfected with the hpIgR cDNA in pCB6 were generated as de-
lium suggests that the CbpA-hpIgR interaction may not scribed by Tamer et al. (1995). Clone hSC-1 was originally isolated
by fluorescence-activated cell sorting (FACS) using a rabbit anti-participate directly in lung infection or alter the onset of
hpIgR antibody and was generously provided by P. Davis (Casesepsis. This idea is consistent with the previous finding
Western Reserve University, Cleveland, OH). MDCK clones pWEthat the CbpA deficiency in pneumococci does not affect
and A4 stably transfected with the rpIgR cDNA were describedthe LD50 if mice are infected via injection (Rosenow et
previously (Breitfeld et al., 1989; Singer and Mostov, 1998). MDCKal., 1997). The PAF receptor has been suggested as
cells stably transfected with the pCB6 vector only were prepared
a cellular receptor for pneumococcal adherence and using a Superfect transfection kit (Qiagen, Valencia, CA) according
invasion of lung epithelial cells and vascular endothelial to the manufacturer’s instructions. An uncloned population desig-
cells (Cundell et al., 1995). It is possible that hpIgR serves nated as Neo-1 was used as a vector control.
as a pneumococcal receptor at the level of nasopharynx, Human cell lines Detroit 562, HEp-2, and A549 were obtained
while the PAF receptor operates in lung epithelium and from ATCC, and maintained as suggested by the supplier. Human
brain microendothelial cell line KC was generously provided by K. S.vascular endothelial cells.
Kim (Children’s Hospital of Los Angeles, Los Angeles, CA), andUpregulation of pIgR expression has been well docu-
cultured as described previously (Ring et al., 1998).mented with a variety of proinflammatory cytokines such
as IFN-g (Sollid et al., 1987; Phillips et al., 1990; Piskurich
Antibodies and Immunoblottinget al., 1993) and IL-1a (Blanch et al., 1999). Promotion
Antisera against recombinant CbpA polypeptides were prepared inof pneumococcal adherence and invasion by IFN-g
New Zealand rabbits by Covance Inc. (Denver, PA) as describedin Detroit cells was due primarily to upregulation of
previously (Sambrook et al., 1989). Rabbit antiserum against hpIgR
hpIgR expression, because treatment with the antibody was prepared in a similar manner by using the purified free SC from
against hpIgR almost completely abolished the effects human colostrum (Kobayashi, 1971). Sheep anti-rpIgR serum was
of the cytokine activation. Cytokine-induced adherence prepared as described previously (Aroeti et al., 1993). Rabbit antise-
and invasion were not observed with the CbpA mutant rum against human PAF receptor and monoclonal antibody against
HSA were obtained from Alexis Biochemicals (San Diego, CA) andand was blocked by anti-CbpA antiserum. A number of
Zymed Laboratories (San Francisco, CA), respectively. Immunoblot-viral and bacterial infections can induce cytokine pro-
ting was carried out as described previously (Zhang et al., 1999).duction (Estcourt et al., 1998; Svanborg et al., 1999).
Streptavidin-peroxidase conjugate was obtained from Pierce (Rock-This may explain why pneumococcal diseases occur
ford, IL).commonly after other bacterial and viral infections (Hoe-
prich, 1994; Overturf, 1994; El Ahmer et al., 1999).
Expression of CbpA PolypeptidesStudies on transport of polymeric IgA in rat hepato-
Recombinant polypeptides were expressed using the pQE30-basedcytes and pIgR-transfected MDCK cells have provided protein expression system, and histidine-tagged fusion proteins
much of the current understanding on the mechanisms were purified by chromatography using Ni-nitrilotriacetic acid ac-
for transepithelial transcytosis of various molecules cording to the supplier’s manual (Qiagen). DNA fragments encoding
(Mostov and Cardone, 1995). In MDCK cells, nascent CbpA truncates were PCR amplified under conditions described
pIgR molecules are sorted primarily to the basolateral previously (Zhang et al., 1997). The primers used are as follows:
PR107 (59-CGGATCCACAGAGAACGAGGGAGCT-39) and PR108surface where they bind to dimeric IgA (Mostov, 1994).
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(59-GGTCGACAGCTGGTTTTTCTTTAAC-39) for cbpA1, PR109 coated with CbpA polypeptides (4 3 108) were resuspended in 100
ml of PBS/Mg21/Ca21 and 0.1% Triton X-100, and mixed with 100(59-CGGATCCATGGAGAACGAGGGAGC-39), and PR110 (59-GGT
CGACCCGTTTCTTCACCTACGC-39) for cbpA2, PR111 (59-CGGAT ml of cellular extracts or human free SC (1 mg) for 1 hr at 228C.
Unbound proteins were removed by extensive washing with PBS/CCCCAGAAAAAAAGGTAGC-39), and PR112 (59-CGAGCTCTGCT
GCTTTTCGTTTAGC-39) for cbpA3, PR105 (59-CGGATCCGCGAC Mg21/Ca21 and 0.1% Triton X-100. The beads were then resus-
pended in SDS-PAGE loading buffer to solubilize bound proteins.AGAGAACGAGGGAAGTAC-39) and PR106 (59-CGAGCTCCCT
TTTCTCCTGGTTTCAATGTAT-39) for cbpA4. The pneumococcal Proteins were separated in SDS-PAGE gels and detected by immu-
noblot analysis. Human free SC was treated with 20 mM sodiumVncS, a putative membrane protein, has been described by Novak
et al. (1999). The recombinant VncS was constructed using primers periodate (Sigma) according to Woodward et al. (1985).
PR122 (59-GCGCGCGGATCCAAACGAACAGGTTTATTTGCAA
AGA-39) and PR123 (59-GCGCGCGGTCGACGTCATCCCATTTACAT Epithelial Cell Adherence and Invasion
TGTTCAT-39). The amplified DNA fragments were digested with ap- Pneumococcal adherence and invasion assays with epithelial cells
propriate restriction enzymes and cloned in pQE30 plasmid. The were performed in 24-well plates as described previously (Ring et
sequences of all DNA inserts were verified by nucleotide sequence al., 1998).
analysis before proceeding to protein expression in E. coli strain To test inhibition by the human SC or antisera against CbpA,
M15(pREP4). DNA sequence analysis was performed using GCG bacteria were diluted at a concentration of 2 3 107 CFU/ml in 1 ml
programs (Genetics Computer Group, Madison, WI). of MEM containing various dilutions of blocking agents. The PAF
receptor antagonist L123 and its inactive isomer L124 (Biomol, Ply-
mouth Meeting, PA) were dissolved in ethanol (20 mM) and dilutedAffinity Purification of the CbpA Binding Proteins
The CbpA1 protein was dialyzed against 0.1 M MOPS (pH 7.5) and to a final concentration of 2 mM in culture medium before addition
to cell monolayers. The mixtures were incubated for 30 min at 378Cconcentrated to 2.5 mg/ml by Centriplus columns (Amicon, Beverly,
MA). The protein concentrations were determined by using a BioRad and directly added to cell monolayers for adherence or invasion
assays as described above.protein assay reagent (BioRad, Hercules, CA). CbpA1 (10 mg) was
covalently conjugated to 1 ml of Affi-Gel 15 (BioRad) in 0.1 M MOPS To determine the effects of human cytokines on bacterial invasion,
recombinant forms of cytokines (Boehringer Mannheim, Indianapo-(pH 7.5) at 48C as described in the manufacturer’s instructions. The
column was sequentially washed with 20 ml of 100 mM glycine (pH lis, IN) were diluted in culture medium to the following final concen-
trations: IL-1a (10 ng/ml), IL-4 (10 ng/ml), TNFa (10 ng/ml), and IFN-g2.5) and 20 ml of PBS/Ca21/Mg21 buffer (1 mM MgCl and 0.5 mM
CaCl), 0.1% Triton X-100, respectively. Detroit cells were grown to (100 U/ml). The concentrations of human cytokines used in this work
were based on a previous study (Blanch et al., 1999). Cells werecomplete confluence in 150 3 25 mm tissue culture dishes. Cell
surface proteins were labeled with Sulfo-NHS-LC-biotin (Pierce) as treated with 0.5 ml of the cytokine dilutions for 12 hr at 378C before
being used for invasion assays.described (Isberg and Leong, 1990). Cell lysates were prepared
in a 1% Triton X-100 lysis buffer containing EDTA-free protease
inhibitors (Boehringer Mannheim) as described previously (Sam- Transmigration Assay
brook et al., 1989). Cellular debris was removed by centrifugation To perform invasion assays with fully polarized MDCK cells, cells
at 135,000 3 g for 1 hr at 48C. The supernatant was recycled were grown on polycarbonate Transwell filters with a 12 mm insert
through the CbpA1-affinity column for a period of 4 hr at 48C. After diameter (0.4 mm pore size, Corning Costar, Cambridge, MA) to
washing the column with 20 ml of PBS/Ca/Mg buffer and 0.1% confluent monolayers as described (Breitfeld et al., 1989). R6x or
Triton X-100, the bound proteins were eluted in 300 ml fractions with the CbpA mutant (500 ml of 2 3 107 CFU/ml) was added to each
100 mM glycine-HCl (pH 2.5). Proteins in the fractions were analyzed upper chamber to conduct invasion experiments as described
by SDS-PAGE gels and immunoblotting. above.
Transmigration of the pneumococcus across the Detroit cell
monolayers was measured in a two-chamber culture system asN-Terminal Sequencing of the CbpA Binding Proteins
N-terminal amino acid sequences of the 100 and 120 kDa CbpA described by Ring et al. (1998). The integrity of Detroit cell mono-
layers on Transwell membranes was assessed by measuring thebinding proteins were determined as described (Rosenow et al.,
1997). In brief, the protein-containing fractions eluted from the CbpA transepithelial electrical resistance (TEER) throughout the ex-
periments using the Millicell-Electrical Resistance System (Milli-affinity column were pooled and concentrated by Centriplus col-
umns. The purified proteins were resolved by SDS-PAGE and elec- pore). The TEER value for the confluent Detroit monolayer was z160
V cm2.trotransferred to a PVDF membrane. The protein bands were visual-
ized by Coomassie blue staining and excised for automated Edman
degradation. Sequence homology searches were performed at the Mouse Work
National Center for Biotechnology Information using the BLAST pro- The animal work was approved by the Animal Resource Committee
grams (Altschul et al., 1990). at the St. Jude Children’s Research Hospital. pIgR KO mice were
established in C57BL/6J background as described previously (Shi-
mada et al., 1999). Adult 129/Sv-Yestm/sor and 129/SvJ control wereAttachment and Internalization of the CbpA-Coated Beads
Recombinant forms of CbpA were immobilized on 1–3 mm carboxyl- obtained from Jackson laboratory (Bar Harbor, ME). Five female
mice (10–14 weeks old) were each inoculated intranasally with z105ated latex beads with yellow-green fluorescence (Polysciences,
Warrington, PA) according to the supplier’s instructions. Interaction CFU of serotype 4 pneumococcus in 10 ml PBS. Nasopharyngeal
colonization was determined by nasal washing using 10 ml PBS asof CbpA-coated latex beads with the pIgR-expressing epithelial cells
was assessed according to Lecuit et al. (1997). Epithelial cells were described previously (Weiser et al., 1994). In the meantime, blood
samples of the mice (20 ml) were collected, diluted in PBS, andgrown on 12 mm diameter glass coverslips for scanning electron
microscopy or on 10 cm diameter tissue culture dishes (Nunc) for spread on TSA blood plates to determine CFU.
transmission electron microscopy. Protein-coated beads were
washed three times in PBS and resuspended in culture medium to Microscopy
a final concentration of 107 beads/ml. The beads were incubated To visualize bacterial adherence to epithelial cells by light micros-
with cells on coverslips (1 ml per coverslip) or dishes (10 ml per copy, cells were cultured to 50% confluence on Lab-Tek II two-
dish) at 378C for 1 hr in 5% CO2. The cells were washed four times chamber slides (Nalge Nunc International, Naperville, IL). Mono-
with PBS to remove unbound beads. Attachment and internalization layers were infected with 2 3 107 bacteria in 1 ml of cell culture
of the beads were visualized by scanning and transmission electron medium for 1 hr at 378C. After washing with PBS, the monolayers
microscopy methods as previously described (Molinari et al., 1997). were stained with Diff-Quick (Dade Behring Inc., Newark, DE).
To visualize invaded bacteria and CbpA1-coated beads by trans-
mission electron microscopy, cell monolayers were cultured to 80%Precipitation of SC or hpIgR by CbpA-Coated Beads
Binding of hpIgR or free SC to CbpA was assessed by an immuno- confluence in 100 3 20 mm culture dishes and infected with 108
mid-log phase bacteria or 108 of the coated beads as above. Afterprecipitation-like method (Sambrook et al., 1989). Latex beads
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a 2 hr incubation, monolayers were processed as described pre- Kobayashi, K. (1971). Studies on human secretory IgA. Comparative
studies of the IgA-bound secretory piece and the free secretoryviously (Ring et al., 1998). For scanning microscopy, cells were
cultured on 13 mm diameter tissue culture cover slips (Nunc Inc., piece protein. Immunochemistry 8, 785–800.
Naperville, IL) which were placed in 4-well tissue culture plates. Lecuit, M., Ohayon, H., Braun, L., Mengaud, J., and Cossart, P.
Samples were processed as described (Molinari et al., 1997). (1997). Internalin of Listeria monocytogenes with an intact leucine-
rich repeat region is sufficient to promote internalization. Infect.
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